2015•Clinical Lymphoma Myeloma & LeukemiaRequires access

Serum Free Light Chain Assays, not Total Light Chain Assays, are the Standard of Care in the Assessment of Monoclonal Gammopathies

Vânia Hungria, Petros Kampanis, Sharon Allen, Mark T. Drayson, Timothy Plant, Edvan Crusoé, Ana Lucia Peres, Priscilla Cury, Manuella Sampaio, Elyara Maria Soares, Stephen Harding

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Immunoglobulin light chain, Monoclonal, Polyclonal antibodies, Multiple myeloma, Heavy chain, Kappa, Monoclonal antibody, Chain (unit)

Back to paper search Browse research topics Original source

Serum Free Light Chain Assays, not Total Light Chain Assays, are the Standard of Care in the Assessment of Monoclonal Gammopathies — Research Paper | ScholarLens